Delivery Order SPE2DB22D3016-SPE2DB25FBJR7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 4,568,983,540 units of Sumatriptan 20 mg nasal spray, with a ceiling value of $4,342.91 under firm fixed price terms. The award was made on August 4, 2025, with an ultimate completion date of August 5, 2025, and is classified as a non-set-aside, competitively awarded contract. Performance will be conducted at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Sumatriptan 20 mg nasal sprays valued at $1,758.62 with a firm fixed price structure. The contract, which was competitively awarded without a set-aside designation, was executed on May 27, 2025, with an ultimate completion date of May 28, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order represents...
- The Defense Logistics Agency awarded a delivery order valued at $1,094.90 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 5 mg nasal sprays. This firm fixed-price delivery order, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a small-value pharmaceutical procurement executed without set-aside designation through open competition. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $2,059.91 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 5mg nasal spray (6-count units) on August 19, 2025, with completion targeted for September 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Sumatriptan 5 mg nasal sprays with a ceiling value of $2,234.40 under a firm fixed-price contract type. The award, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a competitively awarded, non-set-aside delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order for $1,372.98 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,983,022 units of Sumatriptan 5 mg nasal sprays. The delivery order was issued under an existing indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for...
- This is a federal delivery order award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Sumatriptan 20 mg nasal sprays. The firm-fixed-price delivery order, valued at $1,214.17, has an ultimate completion date of August 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at two hundred eighty-six thousand four hundred forty-two dollars to Amerisourcebergen Drug Corporation for the provision of sumatriptan 20 mg nasal sprays. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle and calls for the delivery of the pharmaceutical products to a facility in Conshohocken, Pennsylvania by July 17, 2023. As a major provider of medical supplies and...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,567,692,724 units of Sumatriptan 20 mg nasal sprays. The $1,566.49 firm fixed-price contract was awarded on March 25, 2025 by the Defense Logistics Agency (DLA), with a period of performance ending on March 26, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This is a $1,597.44 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 20 mg Sumatriptan nasal sprays, with a performance period ending on June 16, 2025. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBJR7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,559.58 to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Sumatriptan 20 mg nasal sprays. This is a firm fixed-price delivery order with an ultimate completion date of September 18, 2025, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. The contract was not set aside for any designated business category and was competitively awarded through open competition. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999.999 billion ceiling value and extends through December 2026. AmerisourceBergen Drug Corp serves as a prime pharmaceutical vendor for the Defense Logistics Agency's Medical Supply Chain, supplying a comprehensive range of medications and medical supplies to support military healthcare programs worldwide. The company's role as a critical federal medical procurer demonstrates its capability to fulfill specialized pharmaceutical requirements across the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/17/25 |